Viewing Study NCT05156268


Ignite Creation Date: 2025-12-24 @ 5:51 PM
Ignite Modification Date: 2025-12-28 @ 6:18 AM
Study NCT ID: NCT05156268
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-17
First Post: 2021-12-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module